Mi-Hyun Kim

10PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 07, 2026
EGFR Mutations and Recurrence Outcomes in Resected Non-Small Cell Lung Cancer: An Updated 2015-2025 Systematic Review and Meta-Analysis.

|Nov 14, 2025
Local consolidative therapy for the primary tumor in EGFR-mutant advanced non-small cell lung cancer following osimertinib plus chemotherapy: a protocol for a single-arm, open-label, phase 2 trial.

Mi-Hyun Kim, Hayoung Seong, Soo Han Kim

|Aug 01, 2025
Enhanced Detection of Druggable Mutations in Non-Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor Tissue.

Mi-Hyun Kim, Soo Han Kim, Hayoung Seong

|May 21, 2025
Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With EGFR-Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study.

Mi-Hyun Kim, Min Ki Lee, Ji Eun Park

|Mar 11, 2023
Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer.

Insu Kim, Hee Yun Seol, Soo Han Kim

|Dec 28, 2021
Amphipathic Small Molecule AZT Compound Displays Potent Inhibitory Effects in Cancer Cell Proliferation.

Pethaiah Gunasekaran, Ho Jin Han, Jung Hoon Choi

Pageof 2

Frequent Collaborators

6 joint publications

Jung Seop Eom

3 joint publications

Insu Kim

1 joint publications

Won Young Kim

1 joint publications

Kwangha Lee